On July 3rd, Gelunhui reported that Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) stated on its investor interaction platform that in 2023, the sales revenue of the company's product "Dust Mite Drops" was 821,023,791.81 yuan, and the sales revenue of "Artemisia Pollen Allergen Sublingual Drops" was 15,309,350.43 yuan.
Clear
All
Quotes
News
Learn
Help
All
US
HK
CN
SG
AU
JP
All
News
Announcements
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
我武生物(300357.SZ):2023年粉尘螨滴剂销售收入8.21亿元
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): Sales revenue of 821 million yuan in 2023 for dust mite drops.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Like
Views 296
Write a comment
Statement
This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report